UDG Healthcase 2017 final results
Adjusted diluted earnings per share (EPS) from continuing operations increased by 17% (23% on a constant currency basis).
· Net revenue growth of 12% (16% on a constant currency basis) to $1,028.5 million.
· Adjusted operating profit growth of 12% (17% on a constant currency basis) to $129.3 million. Adjusted net operating margin stable at 12.6%.
· Adjusted profit before tax up 17% (23% on a constant currency basis) driven by:
o Underlying growth of 13% including the benefit of lower interest charges
o Acquisition growth of 10%
o Offset by adverse foreign exchange movements of 6%.
· Proposed 7.5% increase in final dividend to $9.72c per share, yielding a full year dividend increase of 7% to $13.3c per share.
· Net debt of $53.3 million at 30 September 2017 (0.32x net debt to EBITDA).
